New Drug Approvals Archive - September 2003
Seasonale (ethinyl estradiol and levonorgestrel) Tablets
Date of Approval: September 5, 2003
Company: Barr Laboratories
Treatment for: Contraception
Seasonale (ethinyl estradiol and levonorgestrel) is an extended-cycle oral contraceptive.
Riomet (metformin hydrochloride) Oral Solution
Date of Approval: September 11, 2003
Company: Ranbaxy Pharmaceuticals Inc.
Treatment for: Diabetes Type 2
Riomet is an oral solution formulation of the antihyperglycemic drug metformin indicated for the treatment of type 2 diabetes.
Cubicin (daptomycin ) Injection
Date of Approval: September 12, 2003
Company: Cubist Pharmaceuticals
Treatment for: Skin and Structure Infection, Bacteremia
Cubicin (daptomycin) is a lipopeptide antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bloodstream infections (bacteremia).
Cubicin (daptomycin )
New Dosage Regimen: November 30, 2010
Zomig Nasal Spray (zolmitriptan)
Patient Population Altered: June 12, 2015